Fast EU Approval of Baxter’s H1N1 Flu Vaccine Enabled by EMEA’s...

Vaccine is produced in Vero cell technology.The company claims the vaccine is the first cell culture-based, nonadjuvanted pandemic flu vaccine to get EU clearance.

Broad Institute to Use Genedata’s Small Molecule Screener

The Broad Institute of Harvard and MIT has adopted Genedata’s Screener® for small molecule screening. The Screener will be used in the institute’s contribution...

GSK Furthers Interest in China through Pediatric Vaccines JV with Initial...

JV with WalVax will allow local manufacture of GSK’s measles, mumps, and rubella (MMR) Priorix™. GSK also has Chinese JV for seasonal, prepandemic, and pandemic influenza vaccines.

Theraclone and Zenyaku Sign R&D Alliance for mAbs Against Pandemic and...

Joint effort will exploit Theraclone’s I-START technology platform.The technology is based on the interrogation of memory B-cell archives.

Sandoz Launches Somatropin Biosimilar in Japan

It is the follow-on biologic to Pfizer's Genotropin, indicated for growth hormone deficiency in children and growth disturbance in Turner’s syndrome or chronic renal insufficiency.

FDA Awards Biosearch $3.4M for Surveillance Methods to Be Used in...

Rapid multiplexed assays will be designed on a Luminex® xMap® platform. Targets include Bacillus anthracis (anthrax), Yersinia pestis (plague), and Francisella tularensis (tularemia).

Arginetix Pockets $10.75M to Further R&D of Arginase Inhibitors

Small molecules are being developed for cardiovascular and pulmonary indications. Arginetix closed a $10.75 million Series A financing. The company is developing small molecule inhibitors...

Prodrug of Eisai’s Antifungal to Be Investigated in Chagas

Drugs for Neglected Diseases initiative will carry out clinical trials of ravuconazole prodrug.

J&J Pays Crucell $442.35M as Part of Collaboration to Develop Universal...

The deal includes flu-mAB, a universal product against all influenza A strains including seasonal and pandemic H1N1 and the avian H5N1 strain.

HalcyGen Buys Mayne Pharma International to Secure Full Rights to Lead...

Antifungal SUB-Itraconazole is a super-bioavailable formulation of the synthetic broad-spectrum itraconazole. Johnson & Johnson’s branded version is called Sporanox.